CAR T-Cell Therapy Market 2019 - Opportunity Assessment, Share and Forecast Report To 2024

Chimeric antigen receptor T cells (also known as CAR T cells) are T cells that have been genetically engineered to produce an artificial T-cell receptor. Chimeric antigen receptors (CARs, also known as chimeric immunoreceptors, chimeric T cell receptors or artificial T cell receptors) are receptor proteins that have been engineered to give T cells the new ability to target a specific protein. The receptors are chimeric because they combine both antigen-binding and T-cell activating functions into a single receptor. CAR-T cell therapy uses T cells engineered with CARs for cancer therapy. The premise of CAR-T immunotherapy is to modify T cells to recognize cancer cells in order to more effectively target and destroy them. Scientists harvest T cells from people, genetically alter them, then infuse the resulting CAR-T cells into patients to attack their tumors. CAR-T cells can be either derived from T cells in a patient's own blood (autologous) or derived from the T cells of another healthy donor (allogenic). Once isolated from a person, these T cells are genetically engineered to express a specific CAR, which programs them to target an antigen that is present on the surface of tumors. For safety, CAR-T cells are engineered to be specific to an antigen expressed on a tumor that is not expressed on healthy cells.

The key manufacturers covered in this report:
Celgene (Juno Therapeutics)
Novartis
Gilead (Kite Pharma)
Pfizer
CARsgen Therapeutics
Autolus Therapeutics
Aurora BioPharma
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Collectis
Allogene Therapeutics
Celyad

Get Sample Copy of This Report @ https://www.researchkraft.com/request-sample/949997

Segmentation by product type:
Allogeneic
Autologous

Segmentation by application:
Hospitals
Cancer Research Centers
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

To Get info on this Report, Do Enquiry Here @ https://www.researchkraft.com/send-an-enquiry/949997

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives:

To study and analyze the global CAR T-Cell Therapy market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of CAR T-Cell Therapy market by identifying its various subsegments.
Focuses on the key global CAR T-Cell Therapy players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the CAR T-Cell Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of CAR T-Cell Therapy submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Check Discount @ https://www.researchkraft.com/check-discount/949997

Table of Contents:

2019-2024 Global CAR T-Cell Therapy Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global CAR T-Cell Therapy Market Size 2014-2024
2.1.2 CAR T-Cell Therapy Market Size CAGR by Region
2.2 CAR T-Cell Therapy Segment by Type
2.2.1 Allogeneic
2.2.2 Autologous
2.3 CAR T-Cell Therapy Market Size by Type
2.3.1 Global CAR T-Cell Therapy Market Size Market Share by Type (2014-2019)
2.3.2 Global CAR T-Cell Therapy Market Size Growth Rate by Type (2014-2019)
2.4 CAR T-Cell Therapy Segment by Application
2.4.1 Hospitals
2.4.2 Cancer Research Centers
2.4.3 Others
2.5 CAR T-Cell Therapy Market Size by Application
2.5.1 Global CAR T-Cell Therapy Market Size Market Share by Application (2014-2019)
2.5.2 Global CAR T-Cell Therapy Market Size Growth Rate by Application (2014-2019)

3 Global CAR T-Cell Therapy by Players
3.1 Global CAR T-Cell Therapy Market Size Market Share by Players
3.1.1 Global CAR T-Cell Therapy Market Size by Players (2017-2019)
3.1.2 Global CAR T-Cell Therapy Market Size Market Share by Players (2017-2019)
3.2 Global CAR T-Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

…

About Us:

Research Kraft is one-of-a-kind resellers in the market that caters to its clients with the latest and most updated Market Research Reports and Analysis. Our database comprises of a broad range of reports which has been intricately gathered to assist prime business men and decision makers in every industry segment to conceptualize their strategies. Research Kraft collects customized and syndicated market research reports along with consulting services and business intelligence on an array of industry sectors from across the world.

Contact us:

Email: sales@researchkraft.com